Benzinga's Top Initiations

Analysts at Brean Capital initiated coverage on

with a Buy rating. The target price for Syneron Medical is set to $18. Syneron Medical's shares closed at $11.85 yesterday. Analysts at RBC Capital initiated coverage on

with a Outperform rating. The target price for Marriott International is set to $94. Marriott International's shares closed at $84.83 yesterday. CRT Capital initiated coverage on

with a Buy rating. The target price for Ligand Pharmaceuticals is set to $102. Ligand Pharmaceuticals' shares closed at $63.58 yesterday. Analysts at Barclays initiated coverage on

with a Equal-weight rating. The target price for Monsanto is set to $131. Monsanto's shares closed at $121.30 yesterday.